NuVasive strengthens finance team with 3 appointments — 5 points

Written by Megan Wood | June 11, 2018 | Print  |

NuVasive appointed Lisa Pecora, Tristan Ribar and Marc Rosenbaum to finance roles.

Here are five points:

1. Lisa Pecora is now vice president of global commercial finance. In this role, she manages U.S. and international commercial finance functions.

2. Prior to this appointment, Ms. Pecora was executive vice president and CFO of Carling Communications. She also previously served as director of financial planning and analysis at CareFusion.

3. NuVasive also appointed Tristan Ribar as vice president of corporate finance and treasury.

4. Mr. Ribar most recently worked for Alere. He oversaw budgeting, forecasting, reporting and business analysis before Abbott Laboratories acquired Alere in 2017. He also previously served as director of investor relations at CareFusion.

5. Marc Rosenbaum will take over as corporate controller. He has been with NuVasive for four-plus years. Throughout his career he’s been in various senior accounting positions at Dura Pharmaceuticals, Elan Pharmaceuticals, Gen-Probe and Hologic.

"With these new leadership appointments, along with the rest of the finance team, we are building out the depth of the function through an excellent mix of finance and operations prowess as we focus on key areas to drive growth for NuVasive," said Raj Asarpota, NuVasive EVP and CFO.

More articles on devices:
Global neurostimulation devices market to witness growth in North America, Europe, Asia-Pacific region: 5 observations
K2M exceeds 100th-product milestone with OZARK Cervical Plate Systems clearance: 4 highlights
Medtronic whistleblower lawsuit to play out in court: 3 insights

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months